Third, since insulin resistance has been regarded as the underlying pathophysiology of metabolic syndrome, some factors including plasma norepinephrine levels, various adipocytokine levels, fasting insulin, homeostatic model assessment – insulin resistance (HOMA-IR), and unreported medication use were not measured in this study. The gene discussed is INS; the disease is metabolic syndrome.